Outlook Therapeutics, Inc. (OTLK)

$ 1.20
   
  • Change Today:
    $-0.01
  • 52 Week High: $10.26
  • 52 Week Low: $1.11
  • Currency: US Dollars
  • Shares Issued: 23.91m
  • Volume: 372,605
  • Market Cap: $28.69m
  • RiskGrade: 836

Fundamentals - based on IFRS

  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Income Statement 30-Sep-24 30-Sep-23 30-Sep-22 30-Sep-21 30-Sep-20
Continuing Operations          
Revenue n/a n/a n/a n/a n/a
Operating Profit/(Loss) (71.70) (53.13) (63.07) (51.73) (36.84)
Profit Before Tax (75.36) (58.98) (66.05) (53.16) (38.51)
Profit After Tax (75.37) (58.98) (66.05) (53.16) (35.33)
           
Earnings per Share - Basic (406.00¢) (9,440.00¢) (620.00¢) (700.00¢) (1,340.00¢)
Earnings per Share - Adjusted (406.00¢) (9,440.00¢) (620.00¢) (700.00¢) (1,340.00¢)
           
Dividend per Share n/a n/a n/a n/a n/a
  $ (Millions) $ (Millions) $ (Millions) $ (Millions) $ (Millions)
Balance Sheet 30-Sep-24 30-Sep-23 30-Sep-22 30-Sep-21 30-Sep-20
Assets          
Non-Current Assets          
Property, Plant & Equipment 0.27 0.03 0.07 0.28 0.49
Intangible Assets n/a n/a n/a n/a n/a
Other Non-Current Assets 1.13 1.30 0.94 1.03 1.29
  1.41 1.32 1.01 1.30 1.79
Current Assets          
Inventories n/a n/a n/a n/a n/a
Cash at Bank & in Hand 14.93 23.39 17.40 14.48 12.54
Other Current Assets 12.49 7.59 10.12 7.03 5.41
  27.42 30.98 27.52 21.51 17.94
           
Other Assets n/a n/a n/a n/a n/a
Total Assets 28.82 32.30 28.53 22.81 19.73
Current Liabilities          
Borrowings 29.49 35.56 10.95 0.97 0.27
Other Current Liabilities 13.06 11.18 8.78 5.78 15.62
           
Current Liabilities 42.55 46.73 19.73 6.75 15.89
           
Net Current Assets c(15.14) c(15.75) c7.79 c14.76 c2.06
           
Borrowings 0.25 n/a n/a 10.93 0.95
Other Non-Current Liabilities 59.10 0.01 0.06 0.52 0.07
Non-Current Liabilities 59.35 0.01 0.06 11.45 1.02
           
Other Liabilities n/a n/a n/a n/a n/a
Total Liabilities 101.90 46.74 19.79 18.20 16.91
           
Net Assets (73.08) (14.44) 8.74 4.61 2.83
           
Shareholders Funds (73.08) (14.44) 8.74 4.61 (2.83)
           
Minority Interests/Other Equity n/a n/a n/a n/a n/a
Total Equity (73.08) (14.44) 8.74 4.61 2.83
Cash Flow 30-Sep-24 30-Sep-23 30-Sep-22 30-Sep-21 30-Sep-20
Net Cash Flow From Operating Activities (68.79) (42.97) (56.67) (54.25) (31.79)
Net Cash Flow from Investing Activities n/a n/a n/a n/a (0.90)
Net Cash Flow from Financing Activities 60.33 48.97 59.59 56.19 37.21
Net Increase/Decrease In Cash (8.46) 6.00 2.92 1.94 4.52
Ratios - based on IFRS 30-Sep-24 30-Sep-23 30-Sep-22 30-Sep-21 30-Sep-20
Continuing Operations          
PE Ratio - Adjusted n/a n/a n/a n/a n/a
PEG - Adjusted n/a n/a n/a n/a n/a
Earnings per Share Growth - Adjusted n/a n/a n/a n/a n/a
Dividend Cover n/a n/a n/a n/a n/a
Revenue per Share n/a n/a n/a n/a n/a
Pre-Tax Profit per Share (315.25¢) (246.72¢) (276.29¢) (2.25¢) (161.09¢)
Operating Margin n/a n/a n/a n/a n/a
Return on Capital Employed 173.90% n/a n/a n/a n/a
           
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0%
Dividend per Share Growth n/a n/a n/a n/a n/a
Operating Cash Flow per Share (287.77¢) (179.76¢) (237.07¢) (226.94¢) (132.98¢)
Cash Incr/Decr per Share (35.41¢) 25.08¢ 12.21¢ 0.082¢ 18.91¢
Net Asset Value per Share (exc. Intangibles) (305.68¢) (60.39¢) 36.55¢ 19.27¢ 11.82¢
Net Gearing -20.27% -84.25% -73.70% -55.89% 400.58%

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

Top of Page